Compugen Ltd. Stock
Price
Target price
€1.43
€1.43
-2.110%
-0.03
-2.110%
€3.92
16.06.25 / Tradegate
WKN: 553001 / Symbol: CGEN / Name: Compugen / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Compugen Ltd. Stock
We can see a decrease in the price for Compugen Ltd.. Compared to yesterday it has lost -€0.030 (-2.110%).
With 0 Sell predictions and 1 Buy predictions the community sentiment towards the Compugen Ltd. stock is not clear.
Based on the current price of 1.43 € the target price of 3 € shows a potential of 109.21% for Compugen Ltd. which would more than double the current price.
Pros and Cons of Compugen Ltd. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Compugen Ltd. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Compugen Ltd. | -2.110% | -4.527% | 13.270% | -21.295% | -5.159% | -14.132% | - |
| Protalix Biotherapeutics Inc. | -3.310% | -11.679% | -20.395% | 11.060% | -31.484% | 7.891% | -64.412% |
| Chromadex Corp | -10.170% | -9.402% | 12.766% | 310.853% | 105.825% | 587.642% | 166.332% |
| Intellia Therapeutics Inc | -2.000% | 10.901% | -6.996% | -64.661% | -29.820% | -80.683% | -57.866% |
Comments
Compugen Ltd. (NASDAQ: CGEN) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $4.00 price target on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for CGEN provided by MarketBeat
Compugen Ltd. (NASDAQ: CGEN) had its price target lowered by analysts at Truist Financial Co. from $5.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for CGEN provided by MarketBeat
